Bio-Techne Aktie
| 61,25USD | -1,30USD | -2,08% | 
WKN DE: A12ENG / ISIN: US09073M1045
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 2 600 | 3 000 | 3 050 | 3 100 | 3 100 | 
| Umsatz pro Mitarbeiter in Mio. EUR | 0,36 | 0,37 | 0,37 | 0,37 | 0,39 | 
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 511 | 606 | 621 | 617 | 608 | 
| Summe Anlagevermögen | 1 839 | 1 765 | 2 112 | 2 196 | 1 950 | 
| Summe Aktiva | 2 350 | 2 371 | 2 734 | 2 813 | 2 558 | 
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 779 | 670 | 767 | 744 | 639 | 
| Summe Eigenkapital | 1 571 | 1 701 | 1 967 | 2 069 | 1 919 | 
| Summe Passiva | 2 350 | 2 371 | 2 734 | 2 813 | 2 558 | 
Adresse
| 614 McKinley Place NE, 55413-2610 Minneapolis | |
| Telefon | +1 (612) 379-8854 | 
| Internet | http://www.bio-techne.com | 
Management
| 
						Alpna H. Seth
						 Independent Director  | 
				
| 
						Amy E. Herr
						 Independent Director  | 
				
| 
						Cheryl Bethune
						 Chief Human Resources Officer & Senior VP  | 
				
| 
						David Clair
						 VP-Investor Relations & Corporate Development  | 
				
| 
						Gary Latham
						 Chief Technology Officer & Vice President  | 
				
| 
						James T. Hippel
						 Chief Financial Officer & Executive Vice President  | 
				
| 
						John L. Higgins
						 Independent Director  | 
				
| 
						Joseph D. Keegan
						 Independent Director  | 
				
| 
						Judith Klimovsky
						 Independent Director  | 
				
| 
						Julie L. Bushman
						 Independent Director  | 
				
| 
						Kim Kelderman
						 President, Chief Executive Officer & Director  | 
				
| 
						Martin Wirtz
						 Senior VP-Strategy & Corporate Development  | 
				
| 
						Matthew F. McManus
						 President-Diagnostics & Genomics Segment  | 
				
| 
						Qi Cheng
						 Vice President-Quality & Regulatory  | 
				
| 
						Robert V. Baumgartner
						 Chairman  | 
				
| 
						Rupert J. Vessey
						 Independent Director  | 
				
| 
						Shane V. Bohnen
						 Secretary, Chief Sustainability Officer & SVP  | 
				
| 
						Steven C. Crouse
						 SVP & GM-Analytical Solutions Division  | 
				
| 
						William A. Geist
						 President-Protein Sciences Segment  |